Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
Public ClinicalTrials.gov record NCT00314210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Centre,Double-Blind,Randomised-Withdrawal,Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine SR as Monotherapy in the Maintenance Treatment of Patients With GAD Following an Open-Label Stabilisation Period
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of quetiapine SR compared to placebo in increasing time from randomisation to an anxiety event in patients with generalised anxiety disorder (GAD). PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Study identification
- NCT ID
- NCT00314210
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 575 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2006
- Primary completion
- Not listed
- Completion
- Jul 31, 2007
- Last update posted
- Mar 24, 2009
2006 – 2007
United States locations
- U.S. sites
- 56
- U.S. states
- 23
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mesa | Arizona | — | — |
| Research Site | Peoria | Arizona | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Fresno | California | — | — |
| Research Site | La Mesa | California | — | — |
| Research Site | Oceanside | California | — | — |
| Research Site | Redlands | California | — | — |
| Research Site | Coral Springs | Florida | — | — |
| Research Site | DeLand | Florida | — | — |
| Research Site | Fort Myers | Florida | — | — |
| Research Site | Gainsville | Florida | — | — |
| Research Site | Hialeah | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | North Miami | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Saint Petersberg | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Columbus | Georgia | — | — |
| Research Site | Marietta | Georgia | — | — |
| Research Site | Roswell | Georgia | — | — |
| Research Site | Coeur d'Alene | Idaho | — | — |
| Research Site | Hoffman Estates | Illinois | — | — |
| Research Site | Libertyville | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Lafayette | Indiana | — | — |
| Research Site | Valparaiso | Indiana | — | — |
| Research Site | Prairie Village | Kansas | — | — |
| Research Site | Owensboro | Kentucky | — | — |
| Research Site | Paducah | Kentucky | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Glen Burnie | Maryland | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | Cambridge | Massachusetts | — | — |
| Research Site | Pittsfield | Massachusetts | — | — |
| Research Site | Saint Charles | Missouri | — | — |
| Research Site | Piscataway | New Jersey | — | — |
| Research Site | Cedarhurst | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Avon Lake | Ohio | — | — |
| Research Site | Beechwood | Ohio | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research SIte | Middleburg Heights | Ohio | — | — |
| Research Site | Toledo | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Allentown | Pennsylvania | — | — |
| Research Site | Havertown | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | North Charleston | South Carolina | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | DeSoto | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Wichita Falls | Texas | — | — |
| Research Site | Midvale | Utah | — | — |
| Research Site | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00314210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2009 · Synced Sep 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00314210 live on ClinicalTrials.gov.